Karyopharm Therapeutics (KPTI) Gross Profit Growth (3y) (2022 - 2026)

Karyopharm Therapeutics (KPTI) Gross Profit Growth (3y) (2022 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Gross Profit Growth (3y) (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	9.20%
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	10.09%
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	77.42%
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	28.75%
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	45.27%
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	59.77%
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-45.72%
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	80.79%
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Karyopharm Therapeutics	56.72 Mn	56.72 Mn	32.35 Mn	-

Download Data